Balancing benefit and risk in TSH management of DTC

被引:1
|
作者
Verburg, Frederik A. [1 ]
Luster, Markus [1 ]
机构
[1] Univ Hosp Marburg, Dept Nucl Med, Marburg, Germany
关键词
DIFFERENTIATED THYROID-CARCINOMA; THERAPY; CANCER; AXIS;
D O I
10.1038/nrendo.2018.1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TSH-suppressive therapy and the increased risk of cardiovascular disease in patients with differentiated thyroid cancer (DTC) was previously reported. A recent study by Pajamaki and colleagues found that patients with DTC have a higher risk of atrial fibrillation but a lower all-cause cardiovascular death rate. This study offers insights into this effect.
引用
收藏
页码:136 / U81
页数:2
相关论文
共 50 条
  • [31] Balancing benefit and risk of medicines: a systematic review and classification of available methodologies
    Mt-Isa, Shahrul
    Hallgreen, Christine E.
    Wang, Nan
    Callreus, Torbjorn
    Genov, Georgy
    Hirsch, Ian
    Hobbiger, Stephen F.
    Hockley, Kimberley S.
    Luciani, Davide
    Phillips, Lawrence D.
    Quartey, George
    Sarac, Sinan B.
    Stoeckert, Isabelle
    Tzoulaki, Ioanna
    Micaleff, Alain
    Ashby, Deborah
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (07) : 667 - 678
  • [32] BALANCING RISK AND BENEFIT IN MANAGING IRRITABILITY AND AGITATION IN AUTISM SPECTRUM DISORDER
    Veenstra-VanderWeele, Jeremy
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S126 - S126
  • [33] Balancing Risk and Uncertain Benefit in Pharmacotherapy for Pain in Kidney Transplant Recipients
    Schrauben, Sarah J. J.
    Becker, William C. C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (01): : 3 - 4
  • [34] Agreement in Balancing Benefit and Risk of New Drugs between Patients and Regulators
    Arnardottir, Arna H.
    Dolu, Ilknur
    Krabbe, Paul
    Straus, Sabine M.
    de Graeff, Pieter A.
    Haaijer-Ruskamp, Flora M.
    Mol, Peter G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 284 - 284
  • [35] Balancing the interaction between urban regeneration and flood risk management-A cost benefit approach in ?sti nad Labem
    Hudson, Paul
    Raska, Pavel
    Machac, Jan
    Slavikova, Lenka
    LAND USE POLICY, 2022, 120
  • [36] Balancing Profit, Risk, and Sustainability for Portfolio Management
    Maree, Charl
    Omlin, Christian W.
    2022 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE FOR FINANCIAL ENGINEERING AND ECONOMICS (CIFER), 2022,
  • [37] Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements
    Fahim, Germin
    Toscani, Michael
    Barone, Joseph A.
    Wang, Chris
    Gandhi, Shivani
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (01) : 114 - 117
  • [38] Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements
    Germin Fahim
    Michael Toscani
    Joseph A. Barone
    Chris Wang
    Shivani Gandhi
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 114 - 117
  • [39] Management of thrombophilia: Benefit/risk analysis.
    Djulbegovic, B
    Hozo, I
    Hirsh, J
    BLOOD, 1997, 90 (10) : 3220 - 3220
  • [40] RISK BENEFIT CONSIDERATIONS IN THE MANAGEMENT OF POLYMYALGIA RHEUMATICA
    CHANG, RW
    FINEBERG, HV
    MEDICAL DECISION MAKING, 1983, 3 (04) : 459 - 475